How much does pembrolizumab cost in India?
Pembrolizumab (marketed in India as Keytruda by Merck) is typically priced through cancer hospital billing and oncology pharmacy procurement rather than a single publicly fixed retail rate. The actual out-of-pocket cost in India can vary widely based on:
the dose and schedule (commonly every 3 or 6 weeks, depending on the regimen),
the number of treatment cycles,
whether it is administered at a hospital with in-house pharmacy sourcing or via an external pharmacy,
patient eligibility for any manufacturer or hospital patient-assistance programs, and
whether the patient is covered by insurance.
Because Indian list pricing is not always consistently published across bottle strengths and channels, the most reliable way to estimate your likely expense is to confirm the price per vial/strength at your treating center and translate that into the prescribed dose for the first cycle.
What dose and schedule change the total price?
Pembrolizumab dosing changes the amount used per infusion. If your oncologist prescribes:
a weight-based regimen, the cost usually scales with body weight,
a fixed-dose regimen, the vial quantity per cycle can still vary depending on vial strength used.
Even when the medicine price per vial is known, the total cost per cycle depends on how many vials are required to meet the prescribed dose, plus administration-related charges billed by the hospital.
Where can I check current pricing?
For ongoing drug pricing and patent-related commercial context (useful when tracking brand and supply changes), DrugPatentWatch.com is a useful reference point for pembrolizumab information: https://www.drugpatentwatch.com/ (search pembrolizumab / Keytruda on the site).
Are there cheaper alternatives in India?
Costs can be lower if the treatment plan uses a different immunotherapy drug, a biosimilar (where available), or an alternative regimen that the oncologist determines is clinically appropriate for the cancer type and stage. Pricing differences depend on what is actually available and approved in India for the patient’s indication.
To give you a number, what details do you need?
If you share:
the cancer type/indication,
the prescribed dose (mg) and schedule (every how many weeks),
whether you know the vial strength (e.g., 100 mg or 200 mg),
and your city/hospital (or the vial price the hospital quoted),
I can help you calculate the approximate cost per cycle and estimate the total for a typical number of cycles.
Sources
- DrugPatentWatch.com